Marc R. Arnone

915 total citations
7 papers, 620 citations indexed

About

Marc R. Arnone is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Marc R. Arnone has authored 7 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Marc R. Arnone's work include Melanoma and MAPK Pathways (4 papers), Cancer therapeutics and mechanisms (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Marc R. Arnone is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cancer therapeutics and mechanisms (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Marc R. Arnone collaborates with scholars based in United States and Hungary. Marc R. Arnone's co-authors include Ronald D. Snyder, Alastair J. King, Tara Rheault, David Uehling, Kimberly N. Smitheman, Laurie S. Kane-Carson, Katherine G. Moss, Sylvie Laquerre, Robert H. Sinnamon and Alex G. Waterson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Marc R. Arnone

7 papers receiving 603 citations

Peers

Countries citing papers authored by Marc R. Arnone

Since Specialization

Citations

This map shows the geographic impact of Marc R. Arnone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc R. Arnone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc R. Arnone more than expected).

Fields of papers citing papers by Marc R. Arnone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc R. Arnone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc R. Arnone. The network helps show where Marc R. Arnone may publish in the future.

Co-authorship network of co-authors of Marc R. Arnone

This figure shows the co-authorship network connecting the top 25 collaborators of Marc R. Arnone. A scholar is included among the top collaborators of Marc R. Arnone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc R. Arnone. Marc R. Arnone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions 2013 ·PLoS ONE ·Alastair J. King, Marc R. Arnone, Maureen R. Bleam, Katherine G. Moss, Jingsong Yang, (unknown), Kimberly N. Smitheman, Joseph A. Erhardt, Angela Hughes‐Earle, Laurie S. Kane-Carson, Robert H. Sinnamon, Hongwei Qi, Tara Rheault, David Uehling, Sylvie Laquerre	163
2	Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors 2013 ·ACS Medicinal Chemistry Letters ·Tara Rheault, John Stellwagen, George M. Adjabeng, Keith R. Hornberger, Kimberly G. Petrov, Alex G. Waterson, Scott H. Dickerson, Robert A. Mook, Sylvie Laquerre, Alastair J. King, Olivia W. Rossanese, Marc R. Arnone, Kimberly N. Smitheman, Laurie S. Kane-Carson, Chao Han, Ganesh S. Moorthy, Katherine G. Moss, David Uehling	175
3	Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup 2011 ·Bioorganic & Medicinal Chemistry Letters ·John Stellwagen, George M. Adjabeng, Marc R. Arnone, Scott H. Dickerson, Chao Han, Keith R. Hornberger, Alastair J. King, Robert A. Mook, Kimberly G. Petrov, Tara Rheault, Cynthia M. Rominger, Olivia W. Rossanese, Kimberly N. Smitheman, Alex G. Waterson, David Uehling	22
4	Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B-RafV600E mutation 2009 ·Molecular Cancer Therapeutics ·Sylvie Laquerre, Marc R. Arnone, Katherine G. Moss, Jingsong Yang, Kelly E. Fisher, Laurie S. Kane-Carson, Kimberly N. Smitheman, Jessica Ward, (unknown), Tara Rheault, George M. Adjabeng, Keith R. Hornberger, John Stellwagen, Alex G. Waterson, Chao Han, Robert A. Mook, David Uehling, Alastair J. King	45
5	A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues 2006 ·Proceedings of the National Academy of Sciences ·(unknown), Christine Fernandes, Kang Yan, Hong Zhang, Michael Grooms, Kyung Johanson, Robert H. Sinnamon, Robert B. Kirkpatrick, (unknown), (unknown), Marc R. Arnone, Alastair J. King, Zhihong Lai, Robert A. Copeland, Peter J. Tummino	92
6	Identification of Peptide Substrates for Human MMP-11 (Stromelysin-3) Using Phage Display 2003 ·Journal of Biological Chemistry ·Weijun Pan, Marc R. Arnone, (unknown), Robert H. Grafström, Steven P. Seitz, Zelda R. Wasserman, Charles F. Albright	45
7	Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay 2002 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Ronald D. Snyder, Marc R. Arnone	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact